Potassium Assay in OTC Drug Products by Ion Chromatography

Significance of the Topic

Pharmaceutical quality control increasingly demands methods that are selective, sensitive and aligned with modern compendial standards. Traditional potassium assay techniques such as wet chemistry identification and atomic absorption spectroscopy may lack throughput and specificity. Introducing ion chromatography for over the counter drug products supports faster analyses, improved detection limits and streamlined workflows in compliance with USP modernization efforts.

Objectives and Study Overview

The primary goal was to develop and validate a single ion chromatography method for both identification and quantitative assay of potassium in effervescent formulations of potassium bicarbonate and potassium chloride. This study aimed to demonstrate that a cation exchange approach with non suppressed conductivity detection can replace outdated wet chemistry procedures and atomic absorption techniques in routine pharmaceutical testing.

Methodology

An isocratic ion chromatography method was established using a 4 millimolar nitric acid eluent at a flow rate of 0.9 milliliters per minute. Sample preparation involved dissolving finely powdered effervescent tablets corresponding to ten dosage units in deionized water, diluting to volume and mixing. Method validation followed USP general chapter 1225 covering specificity, linearity, accuracy, precision, intermediate precision and solution stability. Calibration was evaluated from 3.75 to 22.5 milligrams per liter of potassium, representing 25 to 150 percent of the target concentration.

Used Instrumentation

• Ion chromatograph system Metrohm 940 Professional IC Vario
• Cation exchange column Metrosep C6 150×4.0 millimeters with L76 packing and guard column
• Direct conductivity detector
• Column temperature maintained at 30 degrees Celsius
• Injection volume of 20 microliters, run time 20 minutes

Main Results and Discussion

Specificity testing showed no coelution or interference in the potassium peak when comparing diluent, resolution solution, standards and sample matrices. Linearity assessment yielded a correlation coefficient of 0.9999 and a y intercept bias of 0.5 percent at the 100 percent level. System suitability, accuracy and precision parameters met all acceptance criteria detailed in the validation summary. The method demonstrated stable response over typical laboratory timescales and robust recovery of potassium from effervescent tablet matrices.

Benefits and Practical Applications of the Method

• Combines identification and assay in one chromatographic run
• Offers broad calibration range suitable for routine QC
• Eliminates use of metal hydroxide reagents and reduces solvent waste
• Can be extended to other cationic impurities including magnesium, calcium, sodium and ammonium

Future Trends and Potential Applications

Advances may include multi ion determination in a single analysis, integration with mass spectrometric detection for enhanced specificity, high throughput configurations and adoption of greener eluents. Continued alignment of compendial monographs with chromatography and automation technologies will further improve quality assurance in pharmaceutical manufacturing.

Conclusion

A robust ion chromatography method for potassium assay and identification in effervescent drug products was successfully developed and validated. The approach meets USP validation requirements, simplifies the QA QC workflow and offers versatile application to related cation analyses in pharmaceutical formulations.